2.38
price down icon5.18%   -0.13
after-market Handel nachbörslich: 2.33 -0.05 -2.10%
loading
Schlusskurs vom Vortag:
$2.51
Offen:
$2.47
24-Stunden-Volumen:
43,716
Relative Volume:
0.02
Marktkapitalisierung:
$5.63M
Einnahmen:
$453.80K
Nettoeinkommen (Verlust:
$-1.03M
KGV:
-3.3129
EPS:
-0.7184
Netto-Cashflow:
-
1W Leistung:
-5.93%
1M Leistung:
-2.06%
6M Leistung:
-81.29%
1J Leistung:
-86.60%
1-Tages-Spanne:
Value
$2.2475
$2.55
1-Wochen-Bereich:
Value
$2.2475
$2.64
52-Wochen-Spanne:
Value
$2.1204
$41.12

X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Company Profile

Name
Firmenname
X T L Biopharmaceuticals Ltd Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
2
Name
Twitter
@xtlbio
Name
Nächster Verdiensttermin
2026-04-29
Name
Neueste SEC-Einreichungen
Name
XTLB's Discussions on Twitter

Compare XTLB vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
XTLB icon
XTLB
X T L Biopharmaceuticals Ltd Adr
2.38 5.94M 453.80K -1.03M 0 -0.7184
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
435.93 110.28B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
634.62 66.98B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
808.43 50.15B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
295.50 39.71B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
154.89 32.22B 742.00K -1.37B -1.07B -7.0731

X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2015-05-08 Eingeleitet H.C. Wainwright Buy

X T L Biopharmaceuticals Ltd Adr Aktie (XTLB) Neueste Nachrichten

pulisher
May 25, 2026

Wondering what's happening in today's after-hours session? - ChartMill

May 25, 2026
pulisher
May 22, 2026

XTL Biopharmaceuticals Faces Added Nasdaq Delisting Risk Over Late 2025 Annual Report - TipRanks

May 22, 2026
pulisher
May 21, 2026

XTLB Stock Price, Quote & Chart | XTL BIOPHARMACEUTICALS-ADR (NASDAQ:XTLB) - ChartMill

May 21, 2026
pulisher
May 15, 2026

XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise - TipRanks

May 15, 2026
pulisher
May 07, 2026

XTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal - TipRanks

May 07, 2026
pulisher
Apr 30, 2026

XTL Biopharmaceuticals Delays 20-F Amid Subsidiary Liquidation - TipRanks

Apr 30, 2026
pulisher
Apr 29, 2026

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.57% - Investing.com

Apr 29, 2026
pulisher
Apr 29, 2026

XTL Biopharmaceuticals to Acquire PsygaBio in All-Stock Deal to Expand Psychedelic Drug Pipeline - TipRanks

Apr 29, 2026
pulisher
Apr 28, 2026

Unusual VolumeStock ScreenerNews - Finviz

Apr 28, 2026
pulisher
Apr 02, 2026

Top GainersStock ScreenerSnapshot - Finviz

Apr 02, 2026
pulisher
Apr 01, 2026

XTL Biopharmaceuticals Ltd ADR Each REPR 40 share price | XTLB - Hargreaves Lansdown

Apr 01, 2026
pulisher
Apr 01, 2026

Debt to assets ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:HHB0 - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

Total assets of XTL Biopharmaceuticals Ltd. Sponsored ADR – SWB:HHB0 - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

Return on invested capital % of XTL Biopharmaceuticals Ltd. Sponsored ADR – SWB:HHB0 - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

Free cash flow per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:HHB0 - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

Tangible book value per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – SWB:HHB0 - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Trade Ideas — SWB:HHB0 - TradingView

Apr 01, 2026
pulisher
Mar 27, 2026

Diluted earnings per share (diluted EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Cash Flow – LSX:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Average basic shares outstanding of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Total operating expenses of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView — Track All Markets

Mar 27, 2026
pulisher
Mar 27, 2026

EBITDA margin % of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Diluted earnings per share (diluted EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

EBITDA margin % of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Statistics – LSX:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Return on assets % of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Basic earnings per share (basic EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView — Track All Markets

Mar 27, 2026
pulisher
Mar 27, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Statistics – LS:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Basic earnings per share (basic EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 26, 2026

Price to cash flow ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:A41X7J - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Revenue per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:A41X7J - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Statistics – GETTEX:A41X7J - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Balance Sheet – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Diluted earnings per share (diluted EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Total operating expenses of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Gross margin % of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Long term debt to total equity ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Price to sales ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Operating cash flow per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Return on invested capital % of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Return on assets % of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Gross profit of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Operating margin % of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

EBITDA margin % of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Total common shares outstanding of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Return on equity % of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Debt to equity ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:A41X7J - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Long term debt to total assets ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Diluted shares outstanding of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Cash Flow – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Price to cash flow ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026

Finanzdaten der X T L Biopharmaceuticals Ltd Adr-Aktie (XTLB)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$29.66
price down icon 0.98%
$92.25
price up icon 0.12%
$108.87
price up icon 2.48%
$53.86
price down icon 1.17%
ONC ONC
$302.44
price down icon 2.52%
$154.89
price up icon 2.20%
Kapitalisierung:     |  Volumen (24h):